Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate
Clinical trial NCT05226390 · TERMINATED
Trial details
- NCT number
- NCT05226390
- Sponsor
- Hannover Medical School
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2023-11-21
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.